How is Insulin glargine recombinant subcutaneous route dosed?
The dosing of insulin glargine recombinant subcutaneous route varies depending on individual patients and their specific treatment plans. The average doses of this medicine are determined by your doctor or as directed on the label. The dose is measured in units and should be administered once daily at bedtime. Please consult with your healthcare professional for personalized dosing information and guidance.
What is the dosage form of Insulin glargine recombinant subcutaneous route?
Insulin glargine recombinant subcutaneous route is available in the form of a solution for injection. It is available under various brand names such as Basaglar, Lantus, Rezvoglar KwikPen, Semglee, Semglee Pen, and Toujeo. The dose is determined by the patient's blood sugar levels and is prescribed by a doctor. The injection should be clear and colorless; it should not be used if it appears cloudy, thick, or contains particles.
How is Insulin glargine recombinant subcutaneous route administered?
Insulin glargine recombinant subcutaneous route is administered through injection under the skin, typically at bedtime. It should be injected once daily following the dosing instructions provided by a healthcare professional. It is important to use a different body area each time you give yourself a shot and rotate body areas to prevent skin problems from the injections.
What are common precautions when taking Insulin glargine recombinant subcutaneous route?
Common precautions when taking insulin glargine include monitoring for side effects, following instructions from a healthcare professional, avoiding alcohol, not taking other medications without consulting a doctor, double-checking the concentration and dose, rotating injection sites, and adhering to a special meal plan, regular exercise, and blood or urine sugar testing.